NCT01344629View on ClinicalTrials.gov

Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

July 31, 2011

Conditions
Healthy
Interventions
DRUG

Telmisartan/Amlodipin FDC

Telmisartan80mg/Amlodipin5mg FDC

DRUG

Telmisartan

Telmisartan 80 mg tablet

DRUG

Amlodipin

Amlodipin 5mg tablet

Trial Locations (1)

Unknown

1235.28.001 Boehringer Ingelheim Investigational Site, Kumamoto, Kumamoto

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01344629 - Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use | Biotech Hunter | Biotech Hunter